These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26822374)

  • 1. The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review.
    Catalá-López F; Ridao M; Alonso-Arroyo A; García-Altés A; Cameron C; González-Bermejo D; Aleixandre-Benavent R; Bernal-Delgado E; Peiró S; Tabarés-Seisdedos R; Hutton B
    Syst Rev; 2016 Jan; 5():6. PubMed ID: 26822374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
    Melendez-Torres GJ; Auguste P; Armoiry X; Maheswaran H; Court R; Madan J; Kan A; Lin S; Counsell C; Patterson J; Rodrigues J; Ciccarelli O; Fraser H; Clarke A
    Health Technol Assess; 2017 Sep; 21(52):1-352. PubMed ID: 28914229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
    Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
    Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil.
    Campolina AG; Rozman LM; Decimoni TC; Leandro R; Novaes HM; De Soárez PC
    Appl Health Econ Health Policy; 2017 Apr; 15(2):163-172. PubMed ID: 27798797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential sponsorship bias in cost-effectiveness analyses of healthcare interventions: A cross-sectional analysis].
    Catalá-López F; Ridao M
    Aten Primaria; 2017; 49(6):335-342. PubMed ID: 28062088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations.
    Long L; Briscoe S; Cooper C; Hyde C; Crathorne L
    Health Technol Assess; 2015 Jan; 19(8):1-134. PubMed ID: 25629427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
    Cunnama L; Gomez GB; Siapka M; Herzel B; Hill J; Kairu A; Levin C; Okello D; DeCormier Plosky W; Garcia Baena I; Sweeney S; Vassall A; Sinanovic E
    Pharmacoeconomics; 2020 Aug; 38(8):819-837. PubMed ID: 32363543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic evaluation of interventions for infectious diseases in Spain: systematic review and comparative analysis].
    Catalá-López F; García-Altés A; Alvarez-Martín E; Génova-Maleras R; Morant-Ginestar C
    Rev Esp Quimioter; 2011 Sep; 24(3):143-50. PubMed ID: 21947097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis.
    Westwood M; Ramaekers B; Lang S; Armstrong N; Noake C; de Kock S; Joore M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Sep; 20(67):1-178. PubMed ID: 27623692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug consumption rooms in Spain (2000-2013).
    Clua García R
    Salud Colect; 2015 Jun; 11(2):261-82. PubMed ID: 26172101
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.